보건행정학회지 (Health Policy and Management)

  • 제28권3호
  • /
  • Pages.263-271
  • /
  • 2018
  • /
  • 1225-4266(pISSN)
  • /
  • 2289-0149(eISSN)
한국보건행정학회 (Korean Academy of Health Policy and Management)
권호 표지
DOI QR코드

DOI QR Code

우리나라 보건의료 발전을 위한 의료기술평가의 역할

Roles of Health Technology Assessment for Better Health and Universal Health Coverage in Korea

  • Lee, Young Sung (National Evidence-based Healthcare Collaborating Agency)
  • 투고 : 2018.08.19
  • 심사 : 2018.08.21
  • 발행 : 2018.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Health technology assessment (HTA) is defined as multidisciplinary policy analysis to look into the medical, economic, social, and ethical implications of the development, distribution, and use of health technology. Following the recent changes in the social environment, there are increasing needs to improve Korea's healthcare environment by, inter alia, assessing health technologies in an organized, timely manner in accordance with the government's strategies to ensure that citizens' medical expenses are kept at a stable level. Dedicated to HTA and research, the National Evidence-based Healthcare Collaborating Agency (NECA) analyzes and provides grounds on the clinical safety, efficacy, and economic feasibility of health technologies. HTA offers the most suitable grounds for decision making not only by healthcare professionals but also by policy makers and citizens as seen in a case in 2009 where research revealed that glucosamine lacked preventive and treatment effects for osteoarthritis and glucosamine was subsequently excluded from the National Health Insurance's benefit list to stop the insurance scheme from suffering financial losses and citizens from paying unnecessary medical expenses. For the development of HTA in Korea, the NECA will continue exerting itself to accomplish its mission of providing policy support by health technology reassessment, promoting the establishment and use of big data and HTA platforms for public interest, and developing a new value-based HTA system.

키워드

참고문헌

  1. World Health Organization. Basic documents. 48th ed. Geneva: World Health Organization; 2014.
  2. Park CY. Health technology assessment and beneft coverage decisions. Health Welf Forum 2017;(248):43 -56.
  3. Park CY. Institutional implication of health technology assessment and policy issue. Evid Value Healthc 2013;1:7-20.
  4. Ko MJ, Lim TH. Use of big data for evidence-based healthcare. J Korean Med Assoc 2014;57(5):413 -418. DOI: https://doi.org/10.5124/jkma.2014.57.5.413.
  5. Heo DS. Evidence-based healthcare in Korea. J Korean Med Assoc 2009;52(10):934 -935. DOI: https://doi.org/10.5124/jkma.2009.52.10.934.
  6. Five-year plan of the Moon Jae-in Administration. Seoul: The State Affairs Planning Advisory Committee; 2017.
  7. Lee OH, Lee JS, Lee HJ, Kim HR, Choi DS, Kim JH, et al. Survey on patient's medical expenditure for health insurance of 2016. Wonju: National Health Insurance Service; 2017.
  8. Lee YS. Strengthening health insurance coverage and health technology assessment. Korea J Health Educ. In press 2018.
  9. Ministry of Health and Welfare. Organization [Internet]. Sejong: Ministry of Health and Welfare [cited 2018 Jul 9]. Available from: http://www.mohw.go.kr.
  10. National Institute for Health and Care Excellence. Who we are [Internet]. London: National Institute for Health and Care Excellence [cited 2017 Jul 26]. Available from: https://www.nice.org.uk/about/who-we-are.
  11. National Institute for Health and Care Excellence. Technology appraisal guidance [Internet]. London: National Institute for Health and Care Excellence [cited 2017 Nov 30]. Available from: https://www.nice.org.uk/ about/what-we-do/our-programmes/nice-guidance/nice-technology-ap-praisal-guidance.
  12. Shin CM, Lee MY, Ahn JH, Lee Sh, Park CY, Joo YI, et al. The development of clinical management guide for temporary approval of new health technology. Seoul: National Evidence-based Healthcare Collaborating Agency; 2013.
  13. Buckley DI, Ansari M, Butler M, Williams C, Chang C. The refnement of topics for systematic reviews: lessons and recommendations from the effective health care program [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2013 [cited 2017 Dec 10]. Available from: https://efectivehealthcare.ahrq.gov/topics/methods-guidance-topic-refnement/methods.
  14. Patient-Centered Outcomes Research Institute. Research and results [Internet]. Washington (DC): Patient-Centered Outcomes Research Institute [cited 2017 Nov 30]. Available from: https://www.pcori.org/.
  15. Choi SJ, Kim JH, Park CY. A review on national clinical research support system. Evid Value Healthc 2015;1(2):103 -110.
  16. Medical Services Advisory Committee. About MSAC [Internet]. Canberra (ACT): Medical Services Advisory Committee [cited 2017 Nov 30]. Available from: http://www.msac.gov.au/.
  17. Medical Services Advisory Committee. Public summary document: application no. 1361.2: transcatheter aortic valve implantation via transfemoral delivery. Canberra (ACT): Medical Services Advisory Committee; 2016.
  18. Medical Services Advisory Committee. Public summary document: application 1180r: review of items for the surgical treatment of obesity. Canberra (ACT): Medical Services Advisory Committee; 2018.
  19. Australian Government Department of Health. Medicare Benefits Schedule Review [Internet]. Canberra (ACT): Australian Government Department of Health; 2018 [cited 2017 Nov 30]. Available from: http://www.health.gov.au/internet/main/publishing.nsf/content/mbsre-viewtaskforce.
  20. Canadian Agency for Drugs and Technologies in Health. What we do: programs and services [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health [cited 2017 Nov 30]. Available from: https://www.cadth.ca/about-cadth/what-we-do/products-services.
  21. O'Rourke B; Canadian Agency for Drugs and Technologies in Health. Health technology assessment [Internet]. Seoul: National Evidence-based Healthcare Collaborating Agency; 2014 [cited 2017 Nov 30]. Available from: http://hineca.kr.
  22. Health Quality Ontario. Health technology assessment [Internet]. Toronto (ON): Health Quality Ontario [cited 2017 Nov 30]. Available from: http://www.hqontario.ca/Evidence-to-Improve-Care/Health-Technology-Assessment.
  23. Health Quality Ontario. Health technology assessments: methods and process guide: version 2.0. Toronto (ON): Health Quality Ontario; 2018.
  24. Bae JM, Shin EH, Seo HS, Jang BH, Kim JH, Kwak SJ, et al. Safety of comprehensive aortic root and valve repair surgery: a retrospective out-comes research. Seoul: National Evidence-based Healthcare Collaborating Agency; 2010.
  25. Bae JM, Lee HY, Park JE, Lee YJ, Jung SY, Cho JH, et al. Health technology assessment for efectiveness and safety of human placental extracts. Seoul: National Evidence-based Healthcare Collaborating Agency; 2009.
  26. Shin CM, Park JY, Park JJ, Seo SW, Shim JI. Assessment of clinical safety and efcacy for weight loss supplements (garcinia cambogia extract, irvingia gabonensis seed extract) in human. Seoul: National Evidence- based Healthcare Collaborating Agency; 2016.
  27. Park JS, Choi SJ, Hwang JS, Ko EB, Shin MK, Kim SK. The safety and domestic usage of amalgam in dental caries. Seoul: National Evidence-based Healthcare Collaborating Agency; 2014.
  28. Oh MD, Kim HB, Kim HY, Song YG, Kim CJ, Yang MH, et al. A study to improve national healthcare system for overcoming healthcare associated infection and antimicrobial resistance. Seoul: National Evidence-based Healthcare Collaborating Agency; 2011.
  29. Oh MD, Kim HB, Kim HY, Song YG, Kim CJ, Yang MH, et al. Macroeconomic study on the improvement of national healthcare management system to overcome healthcare associated infection and antibiotic resistance. Seoul: National Evidence-based Healthcare Collaborating Agency; 2011.
  30. Lee SM, Jang EJ, Ko MJ, Kim JY, Hong SB, Na SW, et al. Economic evaluation for procalcitonin test in patients with suspected sepsis. Seoul: National Evidence-based Healthcare Collaborating Agency; 2015.
  31. Hyun MK, Kwon JW, Kim JH, Kim JM, Shim JI, Lee NR, et al. A research on evidence-based healthcare for thyroid cancer screening. Seoul: National Evidence-based Healthcare Collaborating Agency; 2012.
  32. Bae SC, Kim SY, Sung YK, Lee EB, Choi CB, Seo HJ, et al. Efectiveness of glucosamine and chondroitin in osteoarthritis. Seoul: National Evidence-based Healthcare Collaborating Agency; 2009.
  33. Jee SM, Lee SH, Park EJ, Park JJ, Kim JY. Determine the status of cosmetic plastic procedure and the development of information booklet for the users. Seoul: National Evidence-based Healthcare Collaborating Agency; 2013.
  34. Joo CK, Tchah HW, Hyon JY, Kim MK, Kim TI, Kim JH, et al. Long-term safety and stability of refractive surgeries in myopia. Seoul: National Evidence-based Healthcare Collaborating Agency; 2010.
  35. Heo YS, Kwon JW, Lee HJ, Choi JE, Song HJ, Oh SH, et al. The clinical effectiveness and economic analysis of bariatric surgery for severe obesity. Seoul: National Evidence-based Healthcare Collaborating Agency; 2011.
  36. Kim YH, Ahn JH, Kim YJ, Kim JM, Park JY, Kang SB, et al. Cost-effectiveness of human papillomavirus vaccination in South Korea. Seoul: National Evidence-based Healthcare Collaborating Agency; 2012.
  37. Lee SK, Jo HJ, Lee MS, Lim SW, Choi SK. Analyzing local evidence on tobacco control to reinforce the national tobacco control policy. Seoul: National Evidence-based Healthcare Collaborating Agency, Ministry of Health and Welfare; 2015.
  38. Lee SK, Park JY, Kim JY, Baek MJ, Park SH, Baek HN. A study on the change of tobacco product use and the regulation of new tobacco by strengthening the smoking cessation policy. Seoul: National Evidence-based Healthcare Collaborating Agency, Ministry of Health and Welfare; 2015.
  39. Bae JM, Ryu HG, Lee HY, Jung SY, Jo JH, Lee NR. Societal consensus formation regarding the withdrawal of meaningless life-sustaining treatment. Seoul: National Evidence-based Healthcare Collaborating Agency; 2009.
  40. Choi JE, Kim MJ, Kim SH, Kim JY, Park CY, Seo SW, et al. 2015 Round table conference for consensus of healthcare and social issues. Seoul: National Evidence-based Healthcare Collaborating Agency; 2015.